Post-market Review of Ezetimibe – Draft Report Public Consultation

Page last updated: 6 January 2017

The public consultation on the draft Ezetimibe Post-market Review Report to the PBAC will open on Monday 30 January 2017 and close at 5pm Friday 10 February 2017.

Interested organisations and individuals will be invited to provide a submission addressing the Draft Report to the Pharmaceutical Benefits Advisory Committee (PBAC). To make a submission please go to the Public Consultation page after 30 January.

Further information about the Review is available on the Ezetimibe Review page.